Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical manifestations and staging system].

I Jinnai1

  • 1Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 5, 2002
PubMed
Summary

Chronic myeloid leukemia (CML) is a progressive blood cancer. It has distinct phases, with the acute crisis phase being difficult to treat.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.

Bone marrow transplantation·2013
Same author

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.

Leukemia·2010
Same author

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.

Leukemia·2007
Same author

HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Virus genes·2001
Same author

Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells.

Leukemia·2001
Same author

De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.

Leukemia research·2001

Area of Science:

  • Hematology
  • Oncology
  • Leukemia Research

Context:

  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm.
  • Diagnosis often occurs incidentally via elevated leukocyte counts.
  • CML progresses through distinct phases: chronic, accelerated, and acute crisis.

Purpose:

  • To describe the natural history and clinical progression of chronic myeloid leukemia.
  • To highlight the diagnostic and prognostic significance of CML phases.

Summary:

  • CML typically begins with a chronic phase lasting 2-6 years, often asymptomatic.
  • The disease can progress to an accelerated or acute crisis phase, characterized by diverse clinical features.
  • The acute crisis phase is refractory to treatment, with a median duration of 3 months.

Impact:

  • Understanding CML phases is crucial for patient management and treatment strategies.
  • The International Bone Marrow Transplantation Registry classification provides a reasonable framework for CML staging.
  • Further research into CML progression and treatment is warranted.

Related Experiment Videos